Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3742951 B1
Publication typeGrant
Publication dateNov 23, 1982
Filing dateAug 9, 1971
Priority dateAug 9, 1971
Publication numberUS 3742951 B1, US 3742951B1, US-B1-3742951, US3742951 B1, US3742951B1
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet

US 3742951 B1
Abstract  available in
Description  available in
Claims  available in
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3886939 *Sep 4, 1973Jun 3, 1975Steve BoxerDevice for alleviating muscular discomfort
US3896789 *Jun 10, 1974Jul 29, 1975Riker Laboratories IncRetinoic acid dipensing pressure sensitive dermotological tape
US3948263 *Aug 14, 1974Apr 6, 1976Minnesota Mining And Manufacturing CompanyBallistic animal implant
US3972995 *Apr 14, 1975Aug 3, 1976American Home Products CorporationDosage form
US4039653 *Jul 21, 1975Aug 2, 1977Defoney, Brenman, Mayes & BaronLong-acting articles for oral delivery and process
US4201211 *Jul 12, 1977May 6, 1980Alza CorporationTherapeutic system for administering clonidine transdermally
US4289749 *Jul 9, 1980Sep 15, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing phenylpropanolamine
US4291014 *Jul 11, 1980Sep 22, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing estradiol diacetate
US4291015 *Jun 26, 1980Sep 22, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing a vasodilator
US4292301 *Jul 9, 1980Sep 29, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing ephedrine
US4292302 *Jul 9, 1980Sep 29, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing terbutaline
US4292303 *Jul 9, 1980Sep 29, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing clonidine
US4294820 *Jul 9, 1980Oct 13, 1981Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing phenylephrine
US4314557 *May 19, 1980Feb 9, 1982Alza CorporationDissolution controlled active agent dispenser
US4336243 *May 4, 1981Jun 22, 1982G. D. Searle & Co.Transdermal nitroglycerin pad
US4420470 *Jan 8, 1982Dec 13, 1983Nitto Electric Industrial Co., Ltd.Percutaneous absorption type pharmaceutical preparation of isosorbide dinitrate or pentaerythritol tetranitrate in pressure-sensitive laminate
US4421737 *Mar 25, 1981Dec 20, 1983Nippon Kayaku Kabushiki KaishaPressure-sensitive adhesive tape or pressure-sensitive adhesive sheet containing nitroglycerin
US4455146 *Mar 2, 1982Jun 19, 1984Hisamitsu Pharmaceutical Co., Ltd.Novel plasters
US4460368 *Jan 20, 1983Jul 17, 1984Almedco, Inc.Trans-dermal medication system
US4460370 *Dec 16, 1982Jul 17, 1984Almedco, Inc.Trans-dermal medication application cell
US4460562 *Mar 30, 1983Jul 17, 1984Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
US4482533 *Mar 28, 1983Nov 13, 1984Key Pharmaceuticals, Inc.Polymeric diffusion matrix containing propranolol
US4482534 *Aug 18, 1983Nov 13, 1984Forest Laboratories, Inc.Nitroglycerin preparations
US4486193 *Feb 4, 1983Dec 4, 1984Alza CorporationMethod for treating ischemic conditions by administering drug by two routes
US4556056 *Jun 9, 1983Dec 3, 1985Max-Planck-Gesellschaft Zur Forderung Der/Wissenschaften E.V.Transparent fluid bandage material and the preparation and use thereof
US4563184 *Oct 17, 1983Jan 7, 1986Bernard KorolSynthetic resin wound dressing and method of treatment using same
US4588580 *Jul 23, 1984May 13, 1986Alza CorporationTransdermal administration of fentanyl and device therefor
US4594240 *Sep 7, 1983Jun 10, 1986Teikoku Seiyaku Kabushiki KaishaSheet-shape adhesive preparation
US4597961 *Jan 23, 1985Jul 1, 1986Etscorn Frank TTranscutaneous application of nicotine
US4605399 *Dec 4, 1984Aug 12, 1986Complex, Inc.Transdermal infusion device
US4614787 *Nov 13, 1984Sep 30, 1986Thermedics, Inc.Drug dispensing wound dressing
US4627852 *Dec 14, 1984Dec 9, 1986Bayer AktiengesellschaftActive compound release systems
US4631227 *Dec 5, 1983Dec 23, 1986Kenji NakamuraToilet article
US4638043 *Aug 23, 1985Jan 20, 1987Thermedics, Inc.Drug release system
US4661104 *Dec 14, 1984Apr 28, 1987Bayer AktiengesellschaftActive compound release systems
US4661105 *Jun 9, 1986Apr 28, 1987Alza CorporationMedical bandage for administering vasodilator drug
US4666441 *Dec 17, 1985May 19, 1987Ciba-Geigy CorporationMulticompartmentalized transdermal patches
US4680172 *Mar 5, 1985Jul 14, 1987Ciba-Geigy CorporationDevices and methods for treating memory impairment
US4704119 *Nov 19, 1986Nov 3, 1987Alza CorporationMethod comprising transdermal and buccal treatment of angina
US4704282 *Jun 29, 1984Nov 3, 1987Alza CorporationTransdermal therapeutic system having improved delivery characteristics
US4725272 *Jun 29, 1981Feb 16, 1988Alza CorporationNovel bandage for administering beneficial drug
US4725439 *Jan 13, 1986Feb 16, 1988Alza CorporationTransdermal drug delivery device
US4727868 *May 20, 1987Mar 1, 1988Thermedics, Inc.Anisotropic wound dressing
US4738670 *Jul 10, 1987Apr 19, 1988Bayer AktiengesellschaftMedicinal plasters
US4743249 *Jun 10, 1987May 10, 1988Ciba-Geigy Corp.Dermal and transdermal patches having a discontinuous pattern adhesive layer
US4749574 *Apr 1, 1987Jun 7, 1988Fujisawa Pharmaceutical Co., Ltd.Sustained-release transdermal delivery preparations
US4751087 *Apr 19, 1985Jun 14, 1988Riker Laboratories, Inc.Transdermal nitroglycerin delivery system
US4751133 *May 11, 1987Jun 14, 1988Thermedics, Inc.Medical patches and processes for producing same
US4765985 *May 20, 1987Aug 23, 1988Ciba-Geigy CorporationDevices and methods for treating memory impairment
US4767787 *Mar 24, 1986Aug 30, 1988Kaken Pharmaceutical Co., Ltd.Sheet-shape adhesive preparation
US4776850 *May 12, 1986Oct 11, 1988Beiersdorf AktiengesellschaftNitrate-containing plaster
US4787888 *Jun 1, 1987Nov 29, 1988University Of ConnecticutDisposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
US4812313 *Dec 14, 1987Mar 14, 1989Alza CorporationMethod for lessening the incidence of anginal attacks
US4822617 *Apr 10, 1987Apr 18, 1989Elan Corporation P.L.C.Drug delivery device
US4824676 *Feb 13, 1987Apr 25, 1989Schering CorporationPhysiological means of enhancing transdermal delivery of drugs
US4830856 *Jan 27, 1987May 16, 1989Peppers James MChelation product
US4834979 *Dec 14, 1987May 30, 1989Alza CorporationMedical bandage for administering beneficial drug
US4836217 *Sep 23, 1985Jun 6, 1989Fischer Torkel IHypersensitivity test means
US4839174 *Oct 5, 1987Jun 13, 1989Pharmetrix CorporationNovel transdermal nicotine patch
US4844903 *Nov 6, 1987Jul 4, 1989Mepha AgProcess for the production of an adhesive plaster
US4846826 *Nov 21, 1986Jul 11, 1989Alza CorporationMethod for treating ischemic conditions
US4849226 *Dec 14, 1987Jul 18, 1989Alza CorporationMethod for increasing oxygen supply by administering vasodilator
US4877618 *Mar 18, 1988Oct 31, 1989Reed Jr Fred DTransdermal drug delivery device
US4879275 *May 27, 1988Nov 7, 1989Nelson Research & Development Co.Penetration enhancers for transdermal delivery of systemic agent
US4880690 *Sep 9, 1988Nov 14, 1989Thermedics, Inc.Perfume patch
US4889721 *Jul 15, 1988Dec 26, 1989Fujisawa Pharmaceutical Co., Ltd.Sustained-release percutaneous preparations
US4898920 *Oct 15, 1987Feb 6, 1990Dow Corning CorporationAdhesive compositions, controlled release compositions and transdermal delivery device
US4906475 *Feb 16, 1988Mar 6, 1990Paco Pharmaceutical ServicesEstradiol transdermal delivery system
US4908027 *Sep 12, 1986Mar 13, 1990Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US4917688 *Jun 27, 1988Apr 17, 1990Nelson Research & Development Co.Bandage for transdermal delivery of systemically-active drug
US4920101 *Sep 30, 1987Apr 24, 1990Nelson Research & Development Co.Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4938759 *Sep 2, 1986Jul 3, 1990Alza CorporationTransdermal delivery device having a rate controlling adhesive
US4943435 *Oct 28, 1988Jul 24, 1990Pharmetrix CorporationProlonged activity nicotine patch
US4954344 *Nov 10, 1988Sep 4, 1990Alza CorporationMethod for treating nocturnal angina
US4959208 *Oct 28, 1988Sep 25, 1990Ppg Industries, Inc.Active agent delivery device
US4969871 *Feb 15, 1989Nov 13, 1990Alza CorporationIntravenous system for delivering a beneficial agent
US4973468 *Mar 22, 1989Nov 27, 1990Cygnus Research CorporationSkin permeation enhancer compositions
US4985016 *Feb 15, 1989Jan 15, 1991Alza CorporationIntravenous system for delivering a beneficial agent
US4997655 *Jun 22, 1988Mar 5, 1991Biogal GyogyszergyarPharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
US5004610 *Jun 14, 1990Apr 2, 1991Alza CorporationSubsaturated nicotine transdermal therapeutic system
US5008110 *Nov 10, 1988Apr 16, 1991The Procter & Gamble CompanyStorage-stable transdermal patch
US5008111 *Dec 14, 1988Apr 16, 1991Schering CorporationPhysiological means of enhancing transdermal delivery of drugs
US5034386 *Aug 17, 1988Jul 23, 1991Whitby Research, Inc.Methods for administration using 1-substituted azacycloalkanes
US5035886 *May 10, 1990Jul 30, 1991Ppg Industries, Inc.Active agent delivery device
US5035894 *Sep 8, 1989Jul 30, 1991Dow Corning CorporationControlled release compositions and transdermal drug delivery device
US5045059 *Aug 15, 1990Sep 3, 1991Alza CorporationIntravenous system for delivering a beneficial agent
US5053227 *Jun 12, 1990Oct 1, 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5059189 *Sep 8, 1987Oct 22, 1991E. R. Squibb & Sons, Inc.Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5059426 *Jun 12, 1990Oct 22, 1991Cygnus Therapeutic SystemsSkin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5071645 *Mar 20, 1991Dec 10, 1991Ppg Industries, Inc.Process of producing an active agent delivery device
US5088977 *Dec 21, 1988Feb 18, 1992Drug Delivery Systems Inc.Electrical transdermal drug applicator with counteractor and method of drug delivery
US5091186 *Aug 15, 1989Feb 25, 1992Cygnus Therapeutic SystemsBiphasic transdermal drug delivery device
US5147339 *Sep 19, 1998Sep 15, 1992Coloplast A/SDressing material for the treatment of wounds, and corpuscles for use in the production thereof
US5151271 *Oct 24, 1989Sep 29, 1992Nitti Electric Industrial Co., Ltd.Pressure-sensitively adhering composite medicinal preparation
US5160320 *Feb 14, 1990Nov 3, 1992Alza CorporationIntravenous system for delivering a beneficial agent
US5173302 *Sep 28, 1990Dec 22, 1992Medtronic, Inc.Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
US5186938 *Aug 7, 1991Feb 16, 1993Key Pharmaceuticals, Inc.Adhesive transdermal dosage layer
US5204339 *Aug 6, 1990Apr 20, 1993Whitby Research, Inc.Penetration enhancers for transdermal delivery of systemic agents
US5234690 *Aug 23, 1991Aug 10, 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5250028 *Aug 9, 1991Oct 5, 1993Alza CorporationIntravenous system for delivering a beneficial agent using permeability enhancers
US5268179 *Feb 14, 1992Dec 7, 1993Ciba-Geigy CorporationUltrasonically sealed transdermal drug delivery systems
US5273755 *Aug 23, 1991Dec 28, 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5273756 *Aug 23, 1991Dec 28, 1993Cygnus Therapeutic SystemsTransdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5284660 *Aug 21, 1992Feb 8, 1994Alza CorporationDelayed onset transdermal delivery device
US5328453 *Feb 12, 1992Jul 12, 1994Drug Delivery Systems Inc.Method for enhancing transdermal drug delivery of electrical drug applicators
US5333621 *May 28, 1993Aug 2, 1994Eric DenzerCondom with transdermal vasodilator
US5342623 *Jun 18, 1993Aug 30, 1994Alza CorporationSubsaturated transdermal therapeutic system having improved release characteristics
US5402777 *Jun 3, 1992Apr 4, 1995Alza CorporationMethods and devices for facilitated non-invasive oxygen monitoring
US5523094 *Jul 20, 1994Jun 4, 1996SynthelaboTransdermal pharmaceutical composition
US5536263 *Mar 30, 1994Jul 16, 1996Lectec CorporationNon-occulusive adhesive patch for applying medication to the skin
US5612382 *Jul 15, 1994Mar 18, 1997Frances B. FikeComposition for percutaneous absorption of pharmaceutically active ingredients
US5613958 *Jun 6, 1995Mar 25, 1997Pp Holdings Inc.Transdermal delivery systems for the modulated administration of drugs
US5633008 *Aug 12, 1993May 27, 1997Osborne; James L.Method of administering nicotine transdermally
US5633009 *Nov 12, 1993May 27, 1997Sano CorporationTransdermal administration of azapirones
US5643905 *Jan 10, 1994Jul 1, 1997Therapie-System Gmbh & Co., KgPharmaceutical formulation for the treatment of nicotine dependence
US5668143 *Nov 3, 1994Sep 16, 1997Merrell Pharmaceuticals Inc.Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
US5670164 *Jan 10, 1994Sep 23, 1997Lts Lohmann Therapie-Systeme Bmgh & Co., KgNitroglycerin-containing patch, a process for the production and the use thereof
US5684017 *Nov 3, 1994Nov 4, 1997Merrell Pharmaceuticals Inc.Benzenesulfonylimine derivatives as inhibitors of IL-1 action
US5728688 *Jun 7, 1995Mar 17, 1998Endoreoherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5741510 *Apr 8, 1996Apr 21, 1998Lectec CorporationAdhesive patch for applying analgesic medication to the skin
US5741511 *Apr 10, 1996Apr 21, 1998Sam Yang Co., Ltd.Transdermal drug delivery device for treating erectile dysfunction
US5776923 *Jan 18, 1994Jul 7, 1998Endorecherche, Inc.Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5780460 *Jun 7, 1995Jul 14, 1998Endoreoherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5798347 *Jun 7, 1995Aug 25, 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5807571 *Oct 7, 1997Sep 15, 1998Lts Lohmann Therapie-Systeme GmbhTransdermal therapeutic systems for administering indole serotonin agonists
US5807849 *Jun 13, 1995Sep 15, 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5817331 *Jun 7, 1995Oct 6, 1998Sano CorporationTransdermal administration of azapirones
US5824671 *Jun 7, 1995Oct 20, 1998Endorecherche IncTherapeutic methods and delivery systems utilizing sex steroid precursors
US5837280 *Jun 7, 1995Nov 17, 1998Sano CorporationTransdermal administration of azapirones
US5837700 *Jun 7, 1995Nov 17, 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5843932 *Jun 7, 1995Dec 1, 1998Endorcaherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5854229 *Jun 7, 1995Dec 29, 1998Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5861170 *Mar 22, 1994Jan 19, 1999Lts Lohmann Therapie-Systeme Gmbh & Co. KgAcetylsalicyclic acid-containing transdermal application system for antithrombotic therapy
US5872114 *Jun 7, 1995Feb 16, 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5912009 *Oct 29, 1997Jun 15, 1999Theratech, Inc.Fatty acid esters of glycolic acid and its salts
US5922700 *Jun 7, 1995Jul 13, 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5939095 *Dec 6, 1994Aug 17, 1999Lts Lohmann Therapie-Systeme GmbhTransdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins in particular soman
US5948434 *Jun 7, 1995Sep 7, 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US5952000 *Oct 29, 1997Sep 14, 1999Theratech, Inc.Fatty acid esters of lactic acid salts as permeation enhancers
US5955455 *Nov 13, 1997Sep 21, 1999Endorecherche, Inc.Therapeutic methods and delivery systems utilizing sex steroid precursors
US6007836 *May 19, 1998Dec 28, 1999Vericade, Inc.Transdermal vasodilator
US6007837 *Feb 3, 1999Dec 28, 1999Alza CorporationDrug delivery devices and process of manufacture
US6096333 *Oct 8, 1997Aug 1, 2000Lectec CorporationMethod of forming adhesive patch for applying medication to the skin
US6096334 *Dec 14, 1998Aug 1, 2000Lectec CorporationAdhesive patch for applying medication to the skin and method
US6165497 *Mar 1, 1991Dec 26, 2000Alza CorporationSubsaturated nicotine transdermal therapeutic system
US6174545Feb 3, 1999Jan 16, 2001Alza CorporationDrug delivery devices and process of manufacture
US6432940Jun 11, 1999Aug 13, 2002Endorecherche, Inc.Uses for androst-5-ene-3β, 17β-diol
US6461596 *Feb 18, 1997Oct 8, 2002Andrea TaylorComposition and method for promoting hair growth
US6465445Jun 11, 1998Oct 15, 2002Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6469227May 12, 2000Oct 22, 2002Lectec CorporationAntipruritic patch
US6548510Feb 8, 2000Apr 15, 2003Lts Lohmann Therapie Systeme AgPharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence
US6627631 *Feb 8, 2000Sep 30, 2003Lts Lohmann Therapie-Systeme AgPharmaceutical composition containing desoxypeganine for the treatment of alcoholism
US6670346Jun 11, 1999Dec 30, 2003Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6884795Jun 10, 2002Apr 26, 2005Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
US6933321Feb 14, 2003Aug 23, 2005Endorecherche, Inc.Antiandrogenic biphenyls
US6964955Jun 10, 2002Nov 15, 2005Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
US6995150Jun 10, 2002Feb 7, 2006Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
US7014630Feb 18, 2004Mar 21, 2006Oxyband Technologies, Inc.Tissue dressing having gas reservoir
US7087640Mar 14, 2003Aug 8, 2006Technology Commercialization CorpSubstance with sedative effect
US7094422Aug 20, 2003Aug 22, 2006Acrux Dds Pty Ltd.Topical delivery of antifungal agents
US7166617Feb 26, 2001Jan 23, 2007Mitsubishi Pharma CorporationCyclic amide derivatives
US7263814Jul 15, 2005Sep 4, 2007Oxyband Technologies, Inc.Method and apparatus for supplying gas to an area
US7393825 *Jun 11, 2003Jul 1, 2008Strakan International LimitedMicrodose therapy
US7429576Dec 30, 2003Sep 30, 2008Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7678391 *Mar 6, 2003Mar 16, 2010Queen's University At KingstonFormulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US7884092Oct 3, 2006Feb 8, 2011Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7914645Jan 3, 2007Mar 29, 2011Dow Corning CorporationSilicone adhesive for adhesion to wet surfaces
US7943603Oct 3, 2006May 17, 2011Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8153162Sep 27, 2006Apr 10, 2012Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US8168232 *Feb 25, 2010May 1, 2012Queen's University At KingstonFormulations and methods of using nitric oxide mimetics in cancer treatment
US8182840May 22, 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US8182841Sep 27, 2006May 22, 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US8187639May 29, 2012Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8188066Oct 3, 2006May 29, 2012Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8207159Apr 18, 2002Jun 26, 2012Hf Arzneimittelforschung GmbhUse of galanthamine for the treatment of pathological manifestations of the central nervous system based on intoxications with psychotropic substances
US8236288Jan 6, 2012Aug 7, 2012Skinmedica, Inc.Melanin modification compositions and methods of use
US8389548Feb 18, 2005Mar 5, 2013Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8420126Apr 16, 2013Tissue Tech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8440235May 14, 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US8455009Apr 23, 2012Jun 4, 2013Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US8460714Jun 11, 2013Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US8778315Feb 26, 2013Jul 15, 2014Allergan, Inc.Melanin modification compositions and methods of use
US8778382Apr 30, 2004Jul 15, 2014Purdue Pharma L.P.Tamper resistant transdermal dosage form
US8790689Nov 18, 2005Jul 29, 2014Purdue Pharma L.P.Tamper resistant transdermal dosage form
US8796416Oct 25, 2011Aug 5, 2014Questcor Pharmaceuticals, IncACTH prophylactic treatment of renal disorders
US8957216Mar 24, 2011Feb 17, 2015Amitech Therapeutic Solutions, Inc.Heterocyclic compounds useful for kinase inhibition
US8992491 *Jan 13, 2011Mar 31, 2015Laboratoires UrgoWound dressing including agglomerates of particles suitable for rapidly gelling or solubilizing
US9044404Feb 26, 2013Jun 2, 2015Allergan, Inc.Melanin modification compositions and methods of use
US9090651Jan 7, 2005Jul 28, 2015Endorecherche, Inc.Helix 12 directed pharmaceutical products
US9161954Mar 12, 2013Oct 20, 2015Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US9161955Mar 13, 2013Oct 20, 2015Tissuetech, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US9161956Mar 13, 2013Oct 20, 2015Tissuetech, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US9175066Apr 26, 2010Nov 3, 2015Tissuetech, Inc.Compositions containing HC-HA complex and methods of use thereof
US9198939Mar 13, 2013Dec 1, 2015Tissuetech, Inc.Purified amniotic membrane compositions and methods of use
US9212151Feb 12, 2015Dec 15, 2015Amitech Therapeutic Solutions, Inc.Heterocyclic compounds useful for kinase inhibition
US20020187963 *Jun 10, 2002Dec 12, 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187965 *Jun 10, 2002Dec 12, 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187966 *Jun 10, 2002Dec 12, 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187967 *Jun 10, 2002Dec 12, 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20020187968 *Jun 10, 2002Dec 12, 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
US20020187970 *Jun 10, 2002Dec 12, 2002Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
US20030181516 *Mar 14, 2003Sep 25, 2003Krylov Boris VladimirovichSubstance with sedative effect
US20030212094 *Feb 26, 2001Nov 13, 2003Haruko YamabeNovel cyclic amide derivatives
US20030215528 *Mar 6, 2003Nov 20, 2003Queens University At KingstonFormulations and methods of using nitric oxide mimetics against a malignant cell phenotype
US20030220632 *May 21, 2003Nov 27, 2003Wolfgang StrasserMethod of using gel sheets for laser treatment
US20040006134 *Feb 14, 2003Jan 8, 2004Endorecherche, Inc.Antiandrogenic biphenyls
US20040081684 *Aug 20, 2003Apr 29, 2004Monash UniversityTopical delivery of antifungal agents
US20040116406 *Apr 18, 2002Jun 17, 2004Klaus OpitzUtilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
US20040132751 *Apr 18, 2002Jul 8, 2004Klaus OpitzUse of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
US20040157812 *Dec 30, 2003Aug 12, 2004Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US20040167145 *Jul 5, 2002Aug 26, 2004Klaus OpitzActive ingredient combination for the pharmacological therapy of nicotine dependence
US20040192683 *Jun 15, 2002Sep 30, 2004Joachim MoormannActive ingredient combination for treating a dependence on addictive substances or narcotics using medicaments
US20040260253 *Feb 18, 2004Dec 23, 2004Rosati Coni F.Method and apparatus for supplying gas to an area
US20050002997 *Apr 30, 2004Jan 6, 2005Howard Stephen A.Tamper resistant transdermal dosage form
US20050053647 *Sep 16, 2004Mar 10, 2005Rudolf MatuschPharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
US20050197300 *Jun 11, 2003Sep 8, 2005Cellegy Pharmaceuticals Inc.Microdose therapy
US20050250749 *Jan 7, 2005Nov 10, 2005Endorecherche, Inc.Helix 12 directed pharmaceutical products
US20050251084 *Jul 15, 2005Nov 10, 2005Rosati Coni FMethod and apparatus for supplying gas to an area
US20060199866 *Apr 16, 2004Sep 7, 2006Joachim MoormannCombination of desoxypeganine and mecamylanine for the treatment of alcohol abuse
US20060200100 *Feb 16, 2006Sep 7, 2006Rosati Coni FMethod and apparatus for supplying gas to an area
US20070027122 *Oct 3, 2006Feb 1, 2007Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US20070027123 *Oct 3, 2006Feb 1, 2007Endorecherche, Inc.Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US20070071828 *Sep 27, 2006Mar 29, 2007Bio-Tissue, Inc.Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US20070231401 *Sep 27, 2006Oct 4, 2007Bio-Tissue, Inc.Amniotic membrane preparations and purified compositions and anti-inflammation methods
US20080161277 *Apr 11, 2007Jul 3, 2008Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
US20080295960 *Jan 3, 2007Dec 4, 2008Schalau Ii Gerald KennethSilicone Adhesive For Adhesion To Wet Surfaces
US20080299087 *Sep 27, 2006Dec 4, 2008Bio-Tissue, Inc.Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US20090042844 *Apr 9, 2008Feb 12, 2009Endorecherche, Inc.17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
US20090062781 *Nov 10, 2008Mar 5, 2009Ed. Geistlich Soehne Ag Fur Chemische IndustrieMethod of using gel sheets for laser treatment
US20100068708 *Mar 18, 2010Wintherix LlcMethods for Identifying Compounds that Modulate WNT Signaling in Cancer Cells
US20100143270 *Feb 21, 2008Jun 10, 2010University Of Louisville Research FoubdationTherapeutic cotinine compositions
US20100241219 *Jun 20, 2006Sep 23, 2010Abbeymoor Medical , IncMedicament delivery article, accessory & system
US20100317635 *Jun 1, 2010Dec 16, 2010Endorecherche, Inc.Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
US20110028543 *Feb 25, 2010Feb 3, 2011Queens University At KingstonFormulations and methods of using nitric oxide mimetics in cancer treatment
US20130018335 *Jan 13, 2011Jan 17, 2013Laboratoires UrgoNovel bandage including agglomerates of particles suitable for rapidly gelling or solubilising
USRE32991 *Jul 25, 1988Jul 18, 1989Thermedics, Inc.Drug dispensing wound dressing
USRE39588Oct 31, 1990Apr 24, 2007Alza CorporationTransdermal drug delivery device
DE2647581A1 *Oct 21, 1976Apr 27, 1978Henkel KgaaBlisterpackung
DE3200369A1 *Jan 8, 1982Aug 5, 1982Nitto Electric Ind CoPharmazeutisches praeparat
DE4301781A1 *Jan 23, 1993Jul 28, 1994Lohmann Therapie Syst LtsNitroglycerinhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
DE102013107024A1Jul 4, 2013May 15, 2014Golden Biotechnology CorporationMethoden und Zusammensetzungen zum Behandeln, Modifizieren und Handhaben von Knochenkrebsschmerz
DE102013107025A1Jul 4, 2013Jul 3, 2014Golden Biotechnology CorporationMethoden und zusammensetzungen zur behanldung von diabetis
DE102013202928A1Feb 22, 2013Aug 29, 2013Golden Biotechnology CorporationVerfahren und Zusammensetzungen zum Behandeln von Krebsmetastasierung
EP0150426A2 *Dec 18, 1984Aug 7, 1985Bayer AgDelivery system for an active substance
EP0150428A2 *Dec 18, 1984Aug 7, 1985Bayer AgDelivery system for an active substance
EP0241806A1 *Apr 1, 1987Oct 21, 1987Fujisawa Pharmaceutical Co., Ltd.Sustained-release transdermal delivery preparations
EP0273004A2 *Nov 16, 1987Jun 29, 1988Ciba-Geigy AgUser-activated therapeutical system
EP0301424A2 *Jul 22, 1988Feb 1, 1989Fujisawa Pharmaceutical Co., Ltd.Sustained-release percutaneous preparations
EP1674068A1Feb 19, 1997Jun 28, 2006Acrux DDS Pty LtdDermal penetration enhancers and drug delivery systems involving same
EP1731157A2Jun 10, 1999Dec 13, 2006Endorecherche, Inc.Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
EP1749533A1Oct 28, 1998Feb 7, 2007Winthrop-University HospitalMetal/thiol biocides
EP2002826A1Nov 13, 2001Dec 17, 2008Euro-Celtique S.A.Titratable dosage transdermal delivery system
EP2087892A2Jun 22, 2000Aug 12, 2009Pharmacia & Upjohn Company LLC(S,S) reboxetine for treating age associated learning and mental disorders
EP2090312A1Jun 22, 2000Aug 19, 2009Pharmacia & Upjohn Company LLC(S,S) reboxetine for treating attention deficit disorder
EP2201840A1Dec 28, 2006Jun 30, 2010Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2386304A2Jun 10, 1999Nov 16, 2011Endorecherche Inc.Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
EP2386305A2Jun 10, 1999Nov 16, 2011Endorecherche Inc.Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
EP2399582A1Jun 10, 1999Dec 28, 2011Endorecherche Inc.Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues
EP2443929A1Dec 28, 2006Apr 25, 2012Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2526771A1Dec 28, 2006Nov 28, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526933A2Dec 28, 2006Nov 28, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2526934A2Dec 28, 2006Nov 28, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529621A1Dec 28, 2006Dec 5, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2529622A1Dec 28, 2006Dec 5, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2530083A1Dec 28, 2006Dec 5, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532234A1Dec 28, 2006Dec 12, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2532235A1Dec 28, 2006Dec 12, 2012Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
EP2650294A1Oct 12, 2010Oct 16, 2013Pharmacyclics, Inc.Inhibitors of Bruton's Tyrosine Kinase
EP2664337A1Sep 27, 2006Nov 20, 2013TissueTech, Inc.Amniotic membrane preparations and purified compositions and methods of use
WO1982000005A1 *Jun 26, 1981Jan 7, 1982Key PharmaPolymeric diffusion matrix containing a vasodilator
WO1983000091A1 *Jul 8, 1982Jan 20, 1983Keith, Alec, DellPolymeric diffusion matrix containing 5-ad(3,4-dimethoxyphenethyl)methylaminobd-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
WO1983000092A1 *Jul 8, 1982Jan 20, 1983Key PharmaPolymeric diffusion matrix containing propranolol
WO1983000093A1 *Jul 8, 1982Jan 20, 1983Key PharmaTrinitroglycerol sustained release vehicles and preparation therefrom
WO1987000042A1 *Jun 27, 1986Jan 15, 1987Univ New JerseyTransdermal verapamil delivery device
WO1987001291A1 *Aug 28, 1986Mar 12, 1987Univ New JerseyNovel transdermal anti-anginal pharmaceutical dosage unit and process for its administration
WO1987001935A1 *Oct 1, 1986Apr 9, 1987Vithal J RajadhyakshaTransdermal and systemic preparation and method
WO1994026270A1 *Apr 25, 1994Nov 24, 1994Lohmann Therapie Syst LtsTransdermal therapeutic systems for the administration of serotonin agonists
WO1994027536A1 *May 20, 1994Dec 8, 1994Vericade IncCondom with transdermal vasodilator
WO2004075933A2 *Feb 26, 2004Sep 10, 2004Lavipharm SaDevices for releasing volatile substances and methods of producing the devices
WO2005066194A1Jan 6, 2005Jul 21, 2005Endorech IncHelix 12 directed steroidal pharmaceutical products
WO2007062266A2Nov 28, 2006May 31, 2007Marinus PharmaceuticalsGanaxolone formulations and methods for the making and use thereof
WO2007084266A2 *Jan 3, 2007Jul 26, 2007Dow CorningSilicone adhesive for adhesion to wet surfaces
WO2008021368A2Aug 13, 2007Feb 21, 2008Norman HaugheyCompositions and methods for neuroprotection
WO2008039218A2Dec 28, 2006Apr 3, 2008Pharmacyclics IncInhibitors of bruton's tyrosine kinase
WO2008066899A2Nov 28, 2007Jun 5, 2008Marinus PharmaceuticalsNanoparticulate formulations and methods for the making and use thereof
WO2008109124A1 *Mar 6, 2008Sep 12, 2008Novalar Pharmaceuticals IncUse of nitroglycerin to reverse local anesthesia
WO2008124922A1Apr 11, 2008Oct 23, 2008Endorech Inc17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
WO2010071866A2Dec 19, 2009Jun 24, 2010Nuon Therapeutics, Inc.Combination therapy for arthritis with tranilast
WO2011139489A2Apr 11, 2011Nov 10, 2011Calcimedica Inc.Compounds that modulate intracellular calcium
WO2015084998A1Dec 3, 2014Jun 11, 2015Pharmacyclics, Inc.Inhibitors of bruton's tyrosine kinase
Classifications
International ClassificationA61K9/70
Cooperative ClassificationA61K9/7092, A61K9/7061, A61K9/7084
European ClassificationA61K9/70E2B6B2, A61K9/70E2D, A61K9/70E2K
Legal Events
DateCodeEventDescription
Nov 23, 1982B1Reexamination certificate first reexamination